• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Minimum important difference is minimally important in sample size calculations.最小有意义差异在样本量计算中微不足道。
Trials. 2023 Jan 17;24(1):34. doi: 10.1186/s13063-023-07092-8.
2
The importance of clinical importance when determining the target difference in sample size calculations.在确定样本量计算中的目标差异时,临床重要性的重要性。
Trials. 2023 Aug 4;24(1):495. doi: 10.1186/s13063-023-07532-5.
3
The reassessment of trial perspectives from interim data--a critical view.基于中期数据对试验前景的重新评估——批判性观点。
Stat Med. 2006 Jan 15;25(1):23-36. doi: 10.1002/sim.2180.
4
Significance, Errors, Power, and Sample Size: The Blocking and Tackling of Statistics.意义、误差、功效和样本量:统计学中的拦阻与擒抱。
Anesth Analg. 2018 Feb;126(2):691-698. doi: 10.1213/ANE.0000000000002741.
5
New guidance to improve sample size calculations for trials: eliciting the target difference.改善试验样本量计算的新指南:引出目标差异。
Trials. 2018 Nov 5;19(1):605. doi: 10.1186/s13063-018-2894-y.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Selection of the treatment effect for sample size determination in a superiority clinical trial using a hybrid classical and Bayesian procedure.在使用经典与贝叶斯混合方法的优效性临床试验中,为确定样本量而选择治疗效果。
Contemp Clin Trials. 2015 Mar;41:160-71. doi: 10.1016/j.cct.2015.01.002. Epub 2015 Jan 9.
8
Designing efficient randomized trials: power and sample size calculation when using semiparametric efficient estimators.设计高效的随机临床试验:使用半参数有效估计量时的功效和样本量计算。
Int J Biostat. 2021 Aug 6;18(1):151-171. doi: 10.1515/ijb-2021-0039.
9
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.个性化医学干预的统计学设计:通过遗传学优化抗凝(COAG)试验。
Trials. 2010 Nov 17;11:108. doi: 10.1186/1745-6215-11-108.
10
Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.在使用经典与贝叶斯混合方法的优效性临床试验中,为连续反应确定样本量时效应量的选择。
Clin Trials. 2016 Jun;13(3):275-85. doi: 10.1177/1740774516628825. Epub 2016 Feb 29.

引用本文的文献

1
Quality of Life and Minimal Clinically Important Difference in Colorectal Cancer Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy: A Large Prospective Cohort Study.接受腹腔热灌注化疗的结直肠癌患者的生活质量及最小临床重要差异:一项大型前瞻性队列研究
Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18147-2.
2
A Study on Quantification of the Effects of Heartfulness Meditation Intervention in Healthcare Professionals by Anchor-Based Method in Occupational Health Psychology.职业健康心理学中基于锚定法对医护人员进行心灵冥想干预效果量化的研究
Indian J Occup Environ Med. 2024 Oct-Dec;28(4):272-276. doi: 10.4103/ijoem.ijoem_173_23. Epub 2024 Dec 23.
3
Interpretation of statistical findings in randomised trials: a survey of statisticians using thematic analysis of open-ended questions.随机试验中统计结果的解读:对使用开放式问题的主题分析的统计学家的调查。
BMC Med Res Methodol. 2024 Oct 29;24(1):256. doi: 10.1186/s12874-024-02366-4.
4
An investigation of the association between parenting style and child's dental caries: a cross-sectional study.父母教养方式与儿童龋齿关系的调查:一项横断面研究。
Sci Rep. 2024 Aug 5;14(1):18134. doi: 10.1038/s41598-024-69154-4.
5
Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia.低剂量纳曲酮治疗新冠后疲劳综合征:不列颠哥伦比亚省一项双盲、随机试验的研究方案。
BMJ Open. 2024 May 13;14(5):e085272. doi: 10.1136/bmjopen-2024-085272.
6
Response to Letter from Wong on determining the target difference in sample size calculations for randomised controlled trials.对Wong关于确定随机对照试验样本量计算中目标差异的来信的回复。
Trials. 2024 Mar 2;25(1):161. doi: 10.1186/s13063-024-08023-x.
7
A Comprehensive Study on Tear Meniscus Height Inter-Eye Differences in Aqueous Deficient Dry Eye Diagnosis.水液缺乏型干眼诊断中泪膜半月板高度双眼差异的综合研究
J Clin Med. 2024 Jan 23;13(3):659. doi: 10.3390/jcm13030659.
8
COVID-19 infodemic and health-related quality of life in patients with chronic respiratory diseases: A multicentre, observational study.COVID-19 信息疫情与慢性呼吸系统疾病患者的健康相关生活质量:一项多中心、观察性研究。
J Glob Health. 2023 Nov 10;13:06045. doi: 10.7189/jogh.13.06045.
9
Letter in response to: "The importance of clinical importance when determining the target difference in sample size calculations".对《样本量计算中确定目标差异时临床重要性的重要性》的回复信
Trials. 2023 Oct 12;24(1):666. doi: 10.1186/s13063-023-07695-1.
10
The importance of clinical importance when determining the target difference in sample size calculations.在确定样本量计算中的目标差异时,临床重要性的重要性。
Trials. 2023 Aug 4;24(1):495. doi: 10.1186/s13063-023-07532-5.

本文引用的文献

1
DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.DELTA 指南:选择目标差值以及进行和报告随机对照试验的样本量计算。
BMJ. 2018 Nov 5;363:k3750. doi: 10.1136/bmj.k3750.
2
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review.评估指定随机对照试验目标差值的方法:DELTA(试验中差值确定)综述。
Health Technol Assess. 2014 May;18(28):v-vi, 1-175. doi: 10.3310/hta18280.
3
The role of the minimum clinically important difference and its impact on designing a trial.最小临床重要差异的作用及其对试验设计的影响。
Pharm Stat. 2011 May-Jun;10(3):250-6. doi: 10.1002/pst.459. Epub 2010 Oct 8.
4
Caution regarding the use of pilot studies to guide power calculations for study proposals.关于使用预试验来指导研究方案的功效计算的注意事项。
Arch Gen Psychiatry. 2006 May;63(5):484-9. doi: 10.1001/archpsyc.63.5.484.
5
What are the implications of optimism bias in clinical research?乐观偏差在临床研究中有哪些影响?
Lancet. 2006 Feb 11;367(9509):449-50. doi: 10.1016/S0140-6736(06)68153-1.
6
Sample size calculation for clinical trials: the impact of clinician beliefs.临床试验的样本量计算:临床医生信念的影响
Br J Cancer. 2000 Jan;82(1):213-9. doi: 10.1054/bjoc.1999.0902.

最小有意义差异在样本量计算中微不足道。

Minimum important difference is minimally important in sample size calculations.

机构信息

School of Population & Public Health, University of British Columbia, 2206 East Mall, Vancouver, BC, V6T 1Z3, Canada.

出版信息

Trials. 2023 Jan 17;24(1):34. doi: 10.1186/s13063-023-07092-8.

DOI:10.1186/s13063-023-07092-8
PMID:36650587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9847050/
Abstract

Performing a sample size calculation for a randomized controlled trial requires specifying an assumed benefit (that is, the mean improvement in outcomes due to the intervention) and a target power. There is a widespread belief that judgments about the minimum important difference should be used when setting the assumed benefit and thus the sample size. This belief is misguided - when the purpose of the trial is to test the null hypothesis of no treatment benefit, the only role that the minimum important difference should be given is in determining whether the sample size should be zero, that is, whether the trial should be conducted at all.The true power of the trial depends on the true benefit, so the calculated sample size will result in a true power close to the target power used in the calculation only if the assumed benefit is close to the true benefit. Hence, the assumed benefit should be set to a value that is considered a realistic estimate of the true benefit. If a trial designed using a realistic value for the assumed benefit is unlikely to demonstrate that a meaningful benefit exists, the trial should not be conducted. Any attempt to reconcile discrepancies between the realistic estimate of benefit and the minimum important difference when setting the assumed benefit merely conflates a valid sample size calculation with one based on faulty inputs and leads to a true power that fails to match the target power.When calculating sample size, trial designers should focus efforts on determining reasonable estimates of the true benefit, not on what magnitude of benefit is judged important.

摘要

进行随机对照试验的样本量计算需要指定一个假设的益处(即干预导致的结果平均改善)和目标效力。人们普遍认为,在设定假设益处和样本量时,应该使用最小重要差异的判断。这种信念是有误导性的 - 当试验的目的是检验无治疗益处的零假设时,最小重要差异唯一的作用应该是确定样本量是否应为零,即试验是否应该进行。试验的真实效力取决于真实益处,因此只有当假设益处接近计算中使用的真实益处时,计算出的样本量才会导致真实效力接近目标效力。因此,假设益处应设定为被认为是真实益处的现实估计值。如果使用假设益处的现实值设计的试验不太可能证明存在有意义的益处,则不应进行该试验。当设定假设益处时,试图调和益处的现实估计值和最小重要差异之间的差异,只会将有效的样本量计算与基于错误输入的计算混为一谈,并导致真实效力与目标效力不匹配。在计算样本量时,试验设计者应专注于确定真实益处的合理估计值,而不是判断多大程度的益处是重要的。